3651 - 3700 of 9034 Results
Title
Year
-
OPENTitle: Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 1Start Page: 143End Page: 147Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-160985Best OA location URL: http://doi.org/10.3233/JPD-160985Citation Count: 11
-
OPENTitle: Neuropsychological Subgroups in Non-Demented Parkinson’s Disease: A Latent Class AnalysisJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 2Start Page: 385End Page: 395Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-171081Best OA location URL: http://doi.org/10.3233/JPD-171081Citation Count: 29
-
OPENTitle: Insight into α-Synuclein Plasticity and Misfolding from Differential Micelle BindingJournal Name: The Journal of Physical Chemistry BPublisher: American Chemical Society (ACS)Vol: 117Issue #: 39Start Page: 11448End Page: 11459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jp402589xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3946565Citation Count: 11
-
OPENTitle: Zinc inhibition of rat NR1/NR2AN‐methyl‐d‐aspartate receptorsJournal Name: The Journal of PhysiologyPublisher: WileyVol: 586Issue #: 3Start Page: 763End Page: 778Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1113/jphysiol.2007.143941Best OA location URL: http://doi.org/10.1113/jphysiol.2007.143941Citation Count: 64
-
OPENTitle: Variation in the oxytocin receptor gene is associated with increased risk for anxiety, stress and depression in individuals with a history of exposure to early life stressJournal Name: Journal of Psychiatric ResearchPublisher: Elsevier BVVol: 59Issue #:Start Page: 93End Page: 100Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jpsychires.2014.08.021Best OA location URL: http://doi.org/10.1016/j.jpsychires.2014.08.021Citation Count: 94
-
OPENTitle: Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson’s Disease and Control SubjectsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 4Start Page: 761End Page: 770Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-160888Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5501392Citation Count: 95
-
OPENTitle: Activation of recombinant NR1/NR2C NMDA receptorsJournal Name: The Journal of PhysiologyPublisher: WileyVol: 586Issue #: 18Start Page: 4425End Page: 4439Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1113/jphysiol.2008.158634Best OA location URL: http://doi.org/10.1113/jphysiol.2008.158634Citation Count: 106
- Detraining outcomes with expiratory muscle strength training in Parkinson disease2014RESTRICTEDTitle: Detraining outcomes with expiratory muscle strength training in Parkinson diseaseJournal Name: Journal of Rehabilitation Research and DevelopmentPublisher: Journal of Rehabilitation Research & DevelopmentVol: 51Issue #: 2Start Page: 305End Page: 310Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1682/jrrd.2013.05.0101Citation Count: 55
- The Unified Parkinson�s Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory function2012RESTRICTEDTitle: The Unified Parkinson�s Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory functionJournal Name: The Journal of Rehabilitation Research and DevelopmentPublisher: Journal of Rehabilitation Research & DevelopmentVol: 49Issue #: 8Start Page: 1269End Page: 1269Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1682/jrrd.2011.06.0103Citation Count: 28
-
OPENTitle: Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease GenesJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/835Best OA location URL: https://www.jove.com/pdf/835/application-c-elegans-dopamine-neuron-degeneration-assay-forCitation Count: 47
-
RESTRICTEDTitle: Generation of Stable Transgenic C. elegans Using MicroinjectionJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 18Start Page: 16End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/833Best OA location URL: https://www.jove.com/pdf/833/generation-of-stable-transgenic-c-elegans-using-microinjectionCitation Count: 0
-
OPENTitle: Detection of Protein UbiquitinationJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 30Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/1293Best OA location URL: https://www.jove.com/pdf/1293/detection-of-protein-ubiquitinationCitation Count: 96
-
OPENTitle: Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed inXenopus laevisoocytesJournal Name: The Journal of PhysiologyPublisher: WileyVol: 586Issue #: 1Start Page: 227End Page: 245Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1113/jphysiol.2007.143172Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2375544Citation Count: 99
- Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling2017RESTRICTEDTitle: Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and ModelingJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 123Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/55609Citation Count: 40
- Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs2009RESTRICTEDTitle: Dopamine Release at Individual Presynaptic Terminals Visualized with FFNsJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 30Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/1562Citation Count: 10
-
RESTRICTEDTitle: Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free AssaysJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 126Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/55361Best OA location URL: http://doi.org/10.3791/55361Citation Count: 7
-
OPENTitle: Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive PhosphateJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 79Start Page: e50523End Page: e50523Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/50523Best OA location URL: https://www.jove.com/pdf/50523/metabolic-labeling-leucine-rich-repeat-kinases-1-2-with-radioactiveCitation Count: 5
-
OPENTitle: Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP ExpressionJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 120Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/54981Best OA location URL: https://www.jove.com/pdf/54981/reliable-identification-living-dopaminergic-neurons-midbrain-culturesCitation Count: 9
-
OPENTitle: Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System RegenerationJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 131Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/55848Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5908484Citation Count: 19
-
OPENTitle: Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 2Start Page: 141End Page: 141Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.5528Best OA location URL: http://doi.org/10.1001/jamaneurol.2013.5528Citation Count: 239
-
OPENTitle: Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 1Start Page: 100End Page: 100Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.2704Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/1934714/ncr140023.pdfCitation Count: 402
-
OPENTitle: Cross-Sectional and Longitudinal Relationships Between Cerebrospinal Fluid Biomarkers and Cognitive Function in People Without Cognitive Impairment From Across the Adult Life SpanJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 6Start Page: 742End Page: 742Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.445Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4051849Citation Count: 43
- Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotes2014OPENTitle: Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotesJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 6Start Page: 752End Page: 752Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.313Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4082726Citation Count: 219
-
OPENTitle: Randomized Clinical Trial of 3 Types of Physical Exercise for Patients With Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 70Issue #: 2Start Page: 183End Page: 183Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.646Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4574905Citation Count: 410
-
OPENTitle: Higher Frequency of Certain Cancers inLRRK2G2019S Mutation Carriers With Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 1Start Page: 58End Page: 58Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1973Best OA location URL: http://doi.org/10.1001/jamaneurol.2014.1973Citation Count: 99
-
RESTRICTEDTitle: Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the CommunityJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 73Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2015.3098Best OA location URL: http://doi.org/10.1001/jamaneurol.2015.3098Citation Count: 203
-
OPENTitle: Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity CohortJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 73Issue #: 5Start Page: 515End Page: 515Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2015.4800Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2499458/noi150103.pdfCitation Count: 177
-
OPENTitle: Whole-Exome Sequencing in Familial Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 73Issue #: 1Start Page: 68End Page: 68Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2015.3266Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2470417/noi150080.pdfCitation Count: 76
-
OPENTitle: APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 11Start Page: 1405End Page: 1405Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1455Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/1900308/noi140049.pdfCitation Count: 210
-
OPENTitle: Use of Florbetapir-PET for Imaging β-Amyloid PathologyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 305Issue #: 3Start Page: 275End Page: 275Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2010.2008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7041965Citation Count: 1104
- Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects2014RESTRICTEDTitle: Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction EffectsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 2Start Page: 194End Page: 194Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.2757Citation Count: 164
- Measuring the Lifespace of People With Parkinson’s Disease Using Smartphones: Proof of Principle2014OPENTitle: Measuring the Lifespace of People With Parkinson’s Disease Using Smartphones: Proof of PrincipleJournal Name: JMIR mhealth and uhealthPublisher: JMIR Publications Inc.Vol: 2Issue #: 1Start Page: e13End Page: e13Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/mhealth.2799Best OA location URL: https://mhealth.jmir.org/2014/1/e13/PDFCitation Count: 85
-
OPENTitle: The natural history of multiple system atrophy: a prospective European cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 3Start Page: 264End Page: 274Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s1474-4422(12)70327-7Best OA location URL: http://www.thelancet.com/article/S1474442212703277/pdfCitation Count: 529
-
OPENTitle: Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 7Issue #: 7Start Page: 583End Page: 590Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s1474-4422(08)70117-0Best OA location URL: http://www.thelancet.com/article/S1474442208701170/pdfCitation Count: 1558
-
OPENTitle: Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 10Start Page: 978End Page: 988Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70210-2Best OA location URL: http://doi.org/10.1016/S1474-4422(13)70210-2Citation Count: 269
-
OPENTitle: Long-term Transgene Expression in the Central Nervous System Using DNA NanoparticlesJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 641End Page: 650Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2009.2Best OA location URL: http://www.cell.com/article/S152500161631557X/pdfCitation Count: 80
-
OPENTitle: Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 VectorsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 1490End Page: 1495Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2010.114Best OA location URL: http://www.cell.com/article/S1525001616310991/pdfCitation Count: 81
-
OPENTitle: Comparative Transduction Efficiency of AAV Vector Serotypes 1–6 in the Substantia Nigra and Striatum of the Primate BrainJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 18Issue #: 3Start Page: 588End Page: 593Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2009.286Best OA location URL: http://www.cell.com/article/S1525001616323085/pdfCitation Count: 130
-
OPENTitle: Striatal Pleiotrophin Overexpression Provides Functional and Morphological Neuroprotection in the 6-Hydroxydopamine ModelJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 544End Page: 554Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.216Best OA location URL: http://www.cell.com/article/S1525001616305111/pdfCitation Count: 32
-
OPENTitle: Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 1048End Page: 1057Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.11Best OA location URL: http://www.cell.com/article/S1525001616319098/pdfCitation Count: 143
-
OPENTitle: Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson’s DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 2169End Page: 2180Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2013.169Best OA location URL: http://www.cell.com/article/S1525001616309431/pdfCitation Count: 60
-
OPENTitle: Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBVJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 24Issue #: 3Start Page: 322End Page: 327Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0130-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6363916Citation Count: 72
-
OPENTitle: Intranigral Lentiviral Delivery of Dominant-negative TNF Attenuates Neurodegeneration and Behavioral Deficits in Hemiparkinsonian ratsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 16Issue #: 9Start Page: 1572End Page: 1579Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2008.146Best OA location URL: http://www.cell.com/article/S1525001616320548/pdfCitation Count: 117
-
OPENTitle: Highlights of the Stockholm Congress: A Clinician's PerspectiveJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 4Start Page: 277End Page: 279Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12093Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12093Citation Count: 0
-
OPENTitle: Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy PathologyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 2Issue #: 1Start Page: 33End Page: 38Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12104Citation Count: 5
-
OPENTitle: Neuronal gene expression correlates of Parkinson's disease with dementiaJournal Name: Movement DisordersPublisher: WileyVol: 23Issue #: 11Start Page: 1588End Page: 1595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22184Best OA location URL: http://doi.org/10.1002/mds.22184Citation Count: 51
-
OPENTitle: Using global statistical tests in long‐term Parkinson's disease clinical trialsJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 12Start Page: 1732End Page: 1739Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22645Best OA location URL: http://doi.org/10.1002/mds.22645Citation Count: 42
-
OPENTitle: FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expressionJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 3Start Page: 455End Page: 459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22442Best OA location URL: http://doi.org/10.1002/mds.22442Citation Count: 43
-
OPENTitle: Incidental Lewy body disease: Clinical comparison to a control cohortJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 5Start Page: 642End Page: 646Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22971Best OA location URL: http://doi.org/10.1002/mds.22971Citation Count: 141
- The relationship between uric acid levels and Huntington's disease progression2010RESTRICTEDTitle: The relationship between uric acid levels and Huntington's disease progressionJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 2Start Page: 224End Page: 228Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22907Citation Count: 91